Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2020 Earnings Conference Call May 14, 2020 8:00 AM ET Company Participants Juli Miller - Director of IR Adrian Rawcliffe - CEO Helen Tayton-Martin - Chief Business Officer Elliot Norry - Chief Medical Officer Conference Call Participants Marc Frahm - Cowen and Company Tony Butler - Roth Capital Mohit Bansal - Citigroup Nick Abbott - Wells Fargo Mara Goldstein - Mizuho Operator Ladies and gentlemen, thank you for standing by. And welcome to the Adaptimmune Q1 202 ...